Govt invites EoIs for IMPCL strategic sale

The Indian government has invited bids for the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), in which it holds a 98.11% stake. The remaining 1.89% is held by Kumaon Mandal Vikas Nigam Ltd (KMVNL). The government plans to disinvest its entire stake in IMPCL through strategic disinvestment with a transfer of management control. IMPCL is a profit-making organization that manufactures ayurvedic and unani medicines and supplies them to all states under the National Ayush Mission.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news